Nektar Therapeutics News

Nektar Therapeutics | 8-K: Current report

Apr 17 17:05 ET

Nektar Therapeutics | D: Filing D

Mar 19 16:42 ET

Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.

Mar 15 16:27 ET

Nektar Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Deep Track Capital, LP

Mar 14 16:37 ET

Nektar Therapeutics | 10-K: Annual report

Mar 5 17:16 ET

Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results

Mar 4 16:26 ET

Nektar Therapeutics | 8-K: Current report

Mar 4 08:45 ET

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan

Feb 22 20:23 ET

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew

Feb 22 20:23 ET

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W

Feb 22 20:18 ET

Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 20 15:59 ET

Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 20 15:54 ET

Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 20 15:54 ET

Nektar Therapeutics | 8-K: Current report

Feb 16 17:19 ET

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Feb 14 17:10 ET

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.0%),Citadel Advisors Holdings LP(3.0%), etc.

Feb 14 17:05 ET

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%), etc.

Feb 14 08:58 ET

Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.31%)

Feb 13 22:42 ET

Nektar Therapeutics | 8-K: Current report

Jan 10 00:00 ET

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan

Dec 15, 2023 18:07 ET